- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on MPS II
Total 3046 results
-
Mansoura UniversityCompletedDental Caries Class IIEgypt
-
Alexandria UniversityCompleted
-
University Hospital, Strasbourg, FranceUnknownPeriodontal Disease Stage I/II/IIIFrance
-
Cairo UniversityUnknown
-
King Abdulaziz UniversityCompletedDental Caries Class II
-
Hacettepe UniversityUnknownDental Caries Class IITurkey
-
University of California, San FranciscoNovartisTerminatedLow Grade Glioma | World Health Organization (WHO) Grade II Astrocytomas | Oligodendrogliomas | Mixed OligoastrocytomasUnited States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Mental Health Services in the Capital Region, DenmarkNot yet recruitingBipolar II Disorder
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityRecruitingCaries Class II | Decay, DentalEgypt
-
University of Alberta, Graduate Orthodontic ProgramUnknownOverbite (Excessive) Horizontal
-
TakedaCompletedGrade I or II Essential HypertensionJapan
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease | Glycogenesis 2 Acid Maltase DeficiencyUnited States, Canada, Australia
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Groupe Francophone des MyelodysplasiesAbbVieRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Suspended
-
Nordic MDS GroupCompleted
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Pompe DiseaseUnited States
-
University of AlbertaTerminatedOverbite (Excessive) DeepCanada
-
Ain Shams UniversityRecruitingDental Caries Class IIEgypt
-
Ain Shams UniversityRecruitingDental Caries Class IIEgypt
-
Hacettepe UniversityActive, not recruiting
-
Nourhan M.AlyCompletedClass II Dental CariesEgypt
-
Cairo UniversityActive, not recruiting
-
Cairo UniversityCompleted
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...CompletedFemale Genital Mutilation Type I Status | Female Genital Mutilation Type II Status | Female Genital Mutilation Type III StatusItaly
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedMyelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5qUnited States
-
Synergy Health Concepts, Inc.UnknownVenous Irregularities, Flow and Perfusion in MS and Non-MS ParticipantsUnited States
-
Sunnybrook Health Sciences CentrePrincess Margaret Hospital, Canada; Juravinski Cancer CenterUnknownQuality of Life | Myelodysplastic Syndromes (MDS) | Red Blood Cell (RBC) TransfusionsCanada
-
University Hospital, Basel, SwitzerlandRecruitingHydrocephalus | Ventriculoperitoneal Shunt (VPS)Switzerland
-
Fujian Medical UniversityRecruiting
-
Mana TherapeuticsTerminated
-
Celyad Oncology SAIQVIA BiotechCompletedAML | MDSUnited States, Belgium
-
Genzyme, a Sanofi CompanyRecruitingPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Glycogenesis 2 Acid Maltase DeficiencyCroatia, United States, Italy, Belgium, Czechia
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruiting
-
Aptevo Research and Development LLCRecruiting
-
Damascus UniversityCompletedClass II Division 1 MalocclusionSyrian Arab Republic
-
Genzyme, a Sanofi CompanyTerminatedGlycogenosis 2 | Glycogen Storage Disease Type II (GSD II) | Acid Maltase Deficiency | Pompe Disease (Infantile-Onset)United States, Taiwan, Germany
-
Genzyme, a Sanofi CompanyCompletedGlycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)United States, Netherlands, United Kingdom, Germany
-
Genzyme, a Sanofi CompanyCompletedGlycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)France
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingMyelodysplastic Syndrome (MDS) | Severe Aplastic Anemia | Hypo-Plastic MDSUnited States
-
Cyclacel Pharmaceuticals, Inc.SuspendedLeukemia | Myelodysplastic Syndrome(MDS)United States
-
National Cancer Institute (NCI)CompletedGlioma | Glioblastoma Multiforme | Giant Cell Glioblastoma | Oligodendrogliomas | Astrocytoma, Grades II, III and IVUnited States
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
National Cancer Institute (NCI)WithdrawnMalignant Pleural Mesotheliomas (Mpm) | Malignant Pleural Effusions (Mpe) | Epithelial Tumors, Malignant | Pleural Effusions, Malignant | Mesothelin (Msln)United States
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States